THINNER AND OPTICALLY SUPERIOR DEVICES FOR LOW VISION
适用于低视力人群的更薄、光学性能更佳的设备
基本信息
- 批准号:6072614
- 负责人:
- 金额:$ 31.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-04-01 至 2002-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted From The Applicant's Abstract): A number of vision devices
(particularly those for low vision) make use of high power prismatic
corrections. In these situations, the standard ophthalmic prisms become too
thick, heavy, and impractical. Fresnel prisms are used as alternatives, but
they suffer from a number of problems, including poor optical quality. New
composite prisms were designed and tested in phase I of this project. They have
resulted in a significant reduction in thickness as compared to standard
ophthalmic prisms. For high power prisms, their optical performance is better
than equivalent refractive prisms and far better than Fresnel prisms. As a
result, they could prove useful for a number of vision applications: high
magnification reading spectacles, correction of diplopia, visual field
remediation of hemianopic patients, diagnostics, etc. The aim of phase II is to
establish a process to produce these composite prisms in a cost effective and
reproducible manner, use them to make spectacles and have them tested in
extensive clinical trials by patients suffering from conditions mentioned
above. Briefly put, the aim is to have these devices ready for
commercialization at the conclusion of phase II.
PROPOSED COMMERCIAL APPLICATION:
Composite prisms have the potential to be useful for a number of vision applications where
moderate to high prism powers are needed. Patients suffering from diplopia (double vision),
hemianopia, strabismus, convergence insufficiency and anomalous correspondence could
benefit from these devices. They may also be helpful for patients with restricted visual fields
resulting from strokes or other conditions such as glaucoma and retinitis pigmentosa. Low
vision patients who need high magnification reading spectacles could benefit from composite prisms
as well. For such patients, composite prisms can be used to reduce eye strain and improve the
chances of attaining binocular vision. They could also be useful for conditions such as torticollis
and synostosis where visual image relocation may be needed.
描述(改编自申请人的摘要):
(特别是那些低视力)利用高功率棱镜
更正。在这些情况下,标准眼科棱镜变得太
又厚又重又不实用菲涅耳棱镜被用作替代品,但
但是它们存在许多问题,包括光学质量差。新
在该项目的第一阶段,设计并测试了复合棱镜。他们有
导致与标准相比厚度显著减小
眼科棱镜对于高功率棱镜,它们的光学性能更好
比等效的折射棱镜好得多,也比菲涅耳棱镜好得多。作为
结果,它们可以证明对许多视觉应用有用:高
放大阅读眼镜,复视矫正,视野
偏盲患者的矫正、诊断等。第二阶段的目的是
建立一种生产这些复合棱镜的方法,
以可重复的方式,用它们来制作眼镜,并在
由患有上述病症的患者进行的广泛临床试验
以上简而言之,目的是让这些设备准备好,
在第二阶段结束时实现商业化。
拟定商业应用:
复合棱镜具有用于许多视觉应用的潜力,其中
需要中等到高的棱镜光焦度。 患有复视(复视)的患者,
偏盲、斜视、会聚不足和异常对应可
从这些设备中受益。 它们也可能对视野受限的患者有帮助
由中风或其它病症如青光眼和色素性视网膜炎引起。 低
需要高放大率阅读眼镜的视力患者可以受益于复合棱镜
也 对于这样的患者,可以使用复合棱镜来减少眼睛疲劳并改善视力。
获得双眼视觉的机会。 它们也可能对斜颈等疾病有用
以及可能需要视觉图像重新定位的骨缝结合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RANJANA PANDYA其他文献
RANJANA PANDYA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RANJANA PANDYA', 18)}}的其他基金
THINNER AND OPTICALLY SUPERIOR DEVICES FOR LOW VISION
适用于低视力人群的更薄、光学性能更佳的设备
- 批准号:
6384382 - 财政年份:1997
- 资助金额:
$ 31.96万 - 项目类别:
FLAT OPTICAL ELEMENT FOR DOUBLE VISION CORRECTION
用于双眼矫正的平面光学元件
- 批准号:
2019884 - 财政年份:1997
- 资助金额:
$ 31.96万 - 项目类别:
相似海外基金
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 31.96万 - 项目类别:
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
CAPRISA CASCADE 临床试验网络临床研究网站
- 批准号:
10754981 - 财政年份:2023
- 资助金额:
$ 31.96万 - 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
- 批准号:
10617997 - 财政年份:2022
- 资助金额:
$ 31.96万 - 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
- 批准号:
10538151 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
Admin. Supp. for NCI P30 Cancer Center Grants to Facilitate the Development of Standardized Electronic Treatment Plan Builds for NCI-Supported Clinical Trials Applicable Across Clinical Research Sites
行政。
- 批准号:
10442122 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10624966 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10515803 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10258627 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
- 批准号:
10581505 - 财政年份:2019
- 资助金额:
$ 31.96万 - 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
- 批准号:
10379715 - 财政年份:2019
- 资助金额:
$ 31.96万 - 项目类别: